Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Metrolag Tablets 250mg


May be acceptable

To avoid
Metrolag Tablets 250mg :
Type Medicine Authorised
Originator Flagyl Tablets 250mg
Agent Mediterranean Pharmaceutical Company
Distributor Mediterranean Pharmaceutical Company
Laboratory Lagap
Responsible Party Lagap SA
Origin Switzerland
Manufacturer Labatec Pharma SA
Manufacturing Type G
Origin Switzerland
ATC P01AB01

Your comment will appear shortly after approval

Metrolag Tablets 250mg :

Revision Date : 20/01/2017


Effect Frequency
Acute generalised exanthematous pustulosis (AGEP) Very rare
Agranulocytosis Not known
ALT increased Not known
Anaphylactic shock Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Not known
AST increased Not known
Blood alkaline phosphatase increased Not known
Cephalea Not known
Cerebellar syndrome Not known
Color vision change Not known
Confusion Not known
Convulsion Not known
Delirium Not known
Depressed mood Not known
Diarrhoea (Diarrhea) Not known
Diplopia Not known
Dry mouth (Xerostomia) Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Not known
Encephalopathy Not known
Epigastralgia (Epigastric pain) Not known
Flushing Not known
Glossitis Not known
Hallucination Not known
Hepatic damage Very rare
Hepatic failure (Hepatic insufficiency) (Liver failure) Very rare
Meningitis aseptic Not known
Myopia Not known
Nausea Not known
Neuropathy Not known
Neutropenia Not known
Optic neuritis Not known
Oral fungal infection Not known
Pancreatitis Not known
Paranoia Not known
Peripheral sensory neuropathy Not known
Pruritus Not known
Psychotic reactions Not known
Skin Eruption Not known
Stomatitis Not known
Suicidal ideation Not known
Suicide Not known
Thrombocytopenia (Thrombopenia) Not known
Urine color abnormal Not known
Urticaria Not known
Vertigo Not known
Vision blurred Not known
Visual acuity reduced Not known
Visual disturbance Not known
Vomiting Not known

Different Units By MoH Code

Revision Date : 01/02/2004

Metrolag Tablets 250mg Metrolag Tablets 250mg Metrolag Tablets 250mg Metrolag Tablets 250mg Metrolag Tablets 250mg Metrolag Tablets 250mg

Metrolag Tablets 250mg  MoH 1685 :
Form Tablet
Packaging Blisters
Package Size Box of 20
Strength 250mg
Public Price 130352.72 L.L.
Stratum A1
NSSF ✔
Quarantine ✘
Reg. Number 24873/80
Submission date 01/01/1980
Registration Year 1980


Price Comparison

● Country: UAE
● Package Size: 20's
● Public Price: 24 AED ( 579,864.00 LBP )
● Pack size unit used: 20
● Cost/Unit: 1,2 AED ( 24,161.00 LBP )
● Pharmacy Price: 19.38 AED ( 468240.18 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 20
● Public Price: 130352.72 LBP ( 130,352.72 LBP )
● Pack size unit used: 20
● Cost/Unit: 6517,64 LBP ( 6,517.00 LBP )
● Pricing Date: 13/06/2024

● Country: Abu Dhabi
● Package Size: 20
● Public Price: 10.5 AED ( 253,690.50 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,525 AED ( 0.00 LBP )
● Pharmacy Price: 8.44 AED ( 203918.84 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 20
● Public Price: 1.43 OMR ( 329,949.62 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,0715 OMR ( 0.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 20
● Public Price: 1.28 JOD ( 160,282.88 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,064 JOD ( 0.00 LBP )
● Pharmacy Price: 0.98 JOD ( 122716.58 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 20
● Public Price: 7.55 CHF ( 780,821.00 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,3775 CHF ( 0.00 LBP )
● Exfactory Price: 3.02 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info